Company Filing History:
Years Active: 2017
Title: The Innovations of Matthew Rieser
Introduction
Matthew Rieser is an accomplished inventor based in Sugar Grove, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins that have important applications in medical science.
Latest Patents
Matthew Rieser holds 1 patent for his work on antibodies against platelet-derived growth factor (PDGF). His patent includes binding proteins that interact with one or more of VEGF, PDGF, and their receptors. The patent also covers antibodies, CDR-grafted antibodies, humanized antibodies, binding fragments, fusion proteins, and bispecific or multispecific proteins. Additionally, it discloses methods for making and using these binding proteins.
Career Highlights
Matthew Rieser is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie focuses on innovative solutions that address complex health challenges. His expertise in biotechnology has positioned him as a valuable asset to his team and the company.
Collaborations
Matthew collaborates with talented professionals in his field, including Jijie Gu and Diana Bowley. These collaborations enhance the research and development efforts at AbbVie, leading to groundbreaking advancements in medical technology.
Conclusion
Matthew Rieser exemplifies the spirit of innovation in biotechnology through his patent and contributions at AbbVie Inc. His work on binding proteins has the potential to impact medical treatments significantly.